GLS and hepatocellular carcinoma: Ultimately, synergistic blockade of glutaminolysis and urea cycle indicates that taurine is sufficient to substantially enhance the efficacy of the glutaminase GLS1 inhibitor in management of hepatocellular carcinoma.